03:57 PM EDT, 04/02/2026 (MT Newswires) -- Cresco Labs ( CRLBF ) said Thursday afternoon it was conditionally awarded a license under the Texas Compassionate Use Program, allowing it to cultivate, process, and dispense medical cannabis.

The company said the license supports its state-by-state expansion strategy, with Texas being one of the largest markets in the United States.

"Winning a license in Texas through a merit-based application points to Cresco Labs's ( CRLBF ) deep regulatory expertise and thoughtful approach to meaningful local engagement. Organic licensing enables capital-efficient market entry, and our cash generation and balance sheet give us the financial flexibility to invest and grow a scaled, long-term platform," Chief Executive Charlie Bachtell said.

Cresco shares were last seen up $0.07 to $1.34 on the Canadian Securities Exchange.

Price: 1.34, Change: +0.07, Percent Change: +5.51